Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Which shoulder surgery wins? new trial pits latarjet against bankart repair

NCT ID NCT03585491

Disease control Sponsor: Moin Khan Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares two common surgeries for people with repeat shoulder dislocations: the Latarjet procedure (moving a piece of bone to the shoulder) and the Bankart plus Remplissage procedure (repairing ligaments and tendons). About 86 adults aged 18-50 with mild bone loss are taking part. The main goal is to see if a larger trial is possible, but researchers will also track how often the shoulder dislocates again and how well it functions over two years.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Latarjet procedure or Bankart + Remplissage procedure
What this could lead to
If successful, this could identify which surgical technique is better for preventing repeat shoulder dislocations and improving function.
What could go wrong
This is a small pilot study focused on feasibility, not definitive results. The findings may not apply to all patients, and both surgeries carry standard surgical risks like infection or nerve injury.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

86 people

The number who actually took part.

Started

Jul 2019

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 50 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Men and women ages 18-50 years; * Diagnosis of post-traumatic recurrent anterior dislocation. This will require a minimum of 2 episodes of documented dislocations either by radiographic evidence or documented reduction of anterior shoulder dislocation as well as physical examination eliciting unwanted glenohumeral translation with reproduction of symptoms; * Mild glenoid bone loss as defined on CT by standardized and reproducible best-fit circle technique (\>10% but \<20%); * Provision of informed consent. Exclusion Criteria: * Patients with concomitant injuries (cuff tear); * Previous shoulder surgery; * Patients that will likely have problems, in the judgment of the investigators, with maintaining follow-up; * Epilepsy; * Patients who are or at risk of being incarcerated; * Diagnosis of multidirectional instability; * Cases involving litigation or workplace insurance claims (e.g. WSIB); * Confirmed connective tissue disorder (Ehlers-Danlos, Marfans) or Beighton hypermobility score \> 6. * Pregnancy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anterior dislocation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Shoulder Dislocation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anterior dislocation Shoulder Shoulder dislocation Sport injuries

Contacts and locations

Locations

  • St. Joseph's Healthcare Hamilton

    Hamilton, Ontario, L8N 4A6, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.